Related Experiment Video
Updated: May 29, 2026

Patch Clamp and Perfusion Techniques for Studying Ion Channels Expressed in Xenopus oocytes
Published on: January 10, 2011
Targeting BK (big potassium) channels in epilepsy
1Georgetown University Medical Center, Interdisciplinary Program in Neuroscience and Department of Pediatrics, Washington, DC 20057, USA. pn@georgetown.edu
Large conductance, Ca2+-activated K+ (BKCa) channels are implicated in epilepsy. Both loss-of-function and gain-of-function mutations in BKCa channels can cause seizures, suggesting they are potential drug targets.
Area of Science:
- Neuroscience
- Molecular Biology
- Epileptology
Background:
- Epilepsies are neurological disorders characterized by recurrent seizures due to neuronal hyperexcitability.
- Ion channels, crucial for neuronal excitability, are implicated in epilepsy.
- Large conductance, Ca2+-activated K+ (BKCa) channels play a significant role in seizure etiology.
Purpose of the Study:
- To review the structure-function of BKCa channels.
- To elucidate the role of BKCa channels in epilepsy pathophysiology.
Main Methods:
- Literature review on BKCa channel structure-function.
- Analysis of BKCa channel involvement in various epilepsy models and human epilepsy.
Main Results:
- Loss-of-function BKCa channel mutations are linked to temporal lobe epilepsy, tonic-clonic seizures, and alcohol withdrawal seizures.
- BKCa channel blockade can induce seizures and status epilepticus.
- Gain-of-function mutations in BKCa channel subunits can lead to idiopathic epilepsy, particularly absence epilepsy.
Conclusions:
- Both loss-of-function and gain-of-function BKCa channel alterations contribute to epilepsy.
- BKCa channels represent potential therapeutic targets for suppressing specific seizure phenotypes, including temporal lobe and absence seizures.
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists

